February 5, 2018
Nymox plans submitting NDA for Fexapotide Triflutate, to treat BPH in US
Nymox Pharmaceutical will submit a New Drug Application (NDA) for Fexapotide Triflutate for the treatment of BPH in the US,…
Pharmaceuticals, Biotechnology and Life Sciences
Nymox Pharmaceutical will submit a New Drug Application (NDA) for Fexapotide Triflutate for the treatment of BPH in the US,…